Matthew Douglas Merguerian (Matthew D Merguerian)

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Yu, Natalie T Deuitch, Matthew Douglas Merguerian, Lea Cunningham, Joie Davis, Erica Bresciani, Jamie L Diemer, Elizabeth J Andrews, Alice Young, Frank X Donovan, Raman Sood, Kathleen Marie Craft, Shawn N Chong, Settara C Chandrasekharappa, May Christine V Malicdan, Paul P Liu
Genomic Landscape of Patients with Germline RUNX1 Variants and Familial Platelet Disorder with Myeloid Malignancy. Blood advances (2023)
Paul P Liu, Lea Cunningham, Matthew Douglas Merguerian, Katherine R Calvo, Joie Davis, Natalie T Deuitch, Alina E Dulau-Florea, Nisha Patel, Kai Yu, Keith A Sacco, Sumona Bhattacharya, Monica Passi, Neval Ozkaya, Seila Vanessa De Leon, Shawn Nathan Chong, Kathleen Marie Craft, Jamie L Diemer, Erica Bresciani, Kevin J O'Brien, Elizabeth J Andrews, Nguyen Park, Londa Hathaway, Edward W Cowen, Theo Heller, Kerry Ryan, Amisha V Barochia, Khanh Nghiem, Julie E Niemela, Sergio D Rosenzweig, David J Young, Pamela Frischmeyer-Guerrerio, Raul C Braylan
Natural History Study of Patients with Familial Platelet Disorder with Myeloid Malignancy. Blood (2023)
Tingting Liu, Matthew Douglas Merguerian, Steven P Rowe, Christine A Pratilas, Allen R Chen, Brian H Ladle
Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma. Cold Spring Harbor molecular case studies 7 (4) (2021)

Matthew Douglas Merguerian.css-eqlu8i{font-size:small;padding-left:4px;} (Matthew D Merguerian)